(Q68538394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

title

[Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

author name string

R Preussmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

S Ivankovic

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

C Landschütz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

J Gimmy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

E Flohr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

U Griesbach

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

publication date

1 January 1974

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

Zeitschrift für Krebsforschung und Klinische Onkologie

25 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

285-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

Preparation and antitumor activity of derivatives of 1-phenyl-3,3-dimethyltriazene

25 September 2019

cites work

1 reference

12 December 2020

Mechanism of carcinogenesis with 1-aryl-3,3-dialkyl-triazenes. 3. In vivo methylation of RNA and DNA with 1-phenyl-3,3-( 14 C)-dimethyltriazene.

1 reference

12 December 2020

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of lymphoma

1 reference

12 December 2020

Carcinogenicity and mechanism of action of 1-phenyl-3,3-dimethyltriazene.

1 reference

12 December 2020

[Neurotropic carcinogenic effect of phenyldimethyltriazene on rats]

1 reference

12 December 2020

Studies on the mechanism of action of the tumour inhibitory triazenes

1 reference

12 December 2020

Chemical constitution and mutagenic action. VI. Induction of dominant and recessive lethals by 1-aryl-3, 3-dialkyltriazenes in drosophila

1 reference

12 December 2020

5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanoma

1 reference

12 December 2020

[ON THE REACTION OF MONONUCLEOTIDES WITH DIAZONIUM SALTS]

1 reference

12 December 2020

Clinical study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in carcinoma of the lung

1 reference

12 December 2020

Cancerogenic effect of 1-(p-carboxyethylphenyl)-3,3-dimethyltriazene after s.c. and i.v. administration in rats

1 reference

12 December 2020

Mechanism of carcinogenesis with 1-aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitro.

1 reference

12 December 2020

Clinical experience with 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196) in the treatment of metastatic malignant melanoma

1 reference

12 December 2020

The physiological disposition of the carcinostatic imidazole-4 (or 5)-carboxamide, 5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno] (NSC 82196) (imidazole mustard) in mice and dogs

1 reference

12 December 2020

5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma

1 reference

12 December 2020

Potential Carcinolytic Agents.1 IV. Diazoamino Mustards

1 reference

12 December 2020

Teratogenic effect of 1-phenyl-3,3-dimethyltriazene; production of cleft palates in BD rats

1 reference

12 December 2020

Metabolic activation of aryldialkyltriazenes in the mouse: induction of mitotic gene conversion in Saccharomyces cerevisiae in the host-mediated assay

1 reference

12 December 2020

[Protective arylation of guanosine in position 8 by diazonium salts]

1 reference

12 December 2020

Development of host-mediated mutagenicity tests. I. Differential response of yeast cells injected into testes of rats and peritoneum of mice and rats to mutagens

1 reference

12 December 2020

[QUANTITATIVE ANALYSIS OF THE CARCINOGENIC EFFECT OF DIETHYLNITROSAMINE].

1 reference

12 December 2020

Triazenes, a new group of indirect mutagens. Comparative investigations of the genetic effects of different Aryldialkyltriazenes using Saccharomyces cerevisiae, the host-mediated assay, Drosophila melanogaster, and human chromosomes in vitro.

1 reference

12 December 2020

Methylation of nucleic acids and urinary excretion of 14 C-labeled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole5(4)-carboxomide.

1 reference

12 December 2020

Metabolism of 4(5)-(3,3-dimethyl-1-triazeno)-imidazole-5(4)-carboxamide to 4(5)-aminoimidazole-5(4)-carboxamide in man

1 reference

12 December 2020

Teratogenic effects in rats of growth inhibiting chemicals, including studies on thalidomide

1 reference

12 December 2020

induction of thymic lymphosarcoma and mammary adenocarcinomas in rats by oral administration of the antitumor agent, 4 (5)-(3,3-dimethyl-1-triazeno) imidazole-5 (4)-carboxamide.

1 reference

12 December 2020

[Organotropic carcinogenic effects of 65 various N-nitroso- compounds on BD rats].

1 reference

12 December 2020

[Carcinogenic effect of phenyl-nitroso-urea].

1 reference

12 December 2020

N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man

1 reference

12 December 2020

Studies on the toxicity and pharmacological action of p-dimethyl-aminobenzenediazo sodium sulfonate

1 reference

12 December 2020

5(or 4)-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4(or 5)-carboxamide (NSC-82196)--clinical brochure

1 reference

12 December 2020

Mechanism of carcinogenesis with 1-aryl-3,3-dialkyltriazenes. II. In vitro-alkylation of guanosine, RNA and DNA with aryl-monoalkyltriazenes to form 7-alkylguanine.

1 reference

12 December 2020

Induction of heart tumors in BD-rats by continuous oral administration of the carcinogen 1-pyridyl-3,3-diethyl-triazene (PDET)

1 reference

12 December 2020

THE CARCINOGENICITY OF NITROSOANABASINE, A POSSIBLE CONSTITUENT OF TOBACCO SMOKE

1 reference

12 December 2020

Validity of a linear Hammett plot for the stability of some carcinogenic 1-aryl-3,3-dimethyltriazenes in an aqueous system.

1 reference

12 December 2020

Antitumor activity of triazenoimidazoles

1 reference

12 December 2020

Subcutaneous sarcoma as an index of carcinogenic potency

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00305031

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4279524%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference